ATE209258T1 - Verwendung von rna-polymerase zur verbesserung von nukeinsaeure-amplifikationsverfahren - Google Patents

Verwendung von rna-polymerase zur verbesserung von nukeinsaeure-amplifikationsverfahren

Info

Publication number
ATE209258T1
ATE209258T1 AT95929679T AT95929679T ATE209258T1 AT E209258 T1 ATE209258 T1 AT E209258T1 AT 95929679 T AT95929679 T AT 95929679T AT 95929679 T AT95929679 T AT 95929679T AT E209258 T1 ATE209258 T1 AT E209258T1
Authority
AT
Austria
Prior art keywords
template
rna
dna
reagents
rna polymerase
Prior art date
Application number
AT95929679T
Other languages
English (en)
Inventor
Roy Sooknanan
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE209258T1 publication Critical patent/ATE209258T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT95929679T 1994-07-15 1995-07-13 Verwendung von rna-polymerase zur verbesserung von nukeinsaeure-amplifikationsverfahren ATE209258T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27525094A 1994-07-15 1994-07-15
PCT/CA1995/000423 WO1996002668A1 (en) 1994-07-15 1995-07-13 Use of rna polymerase to improve nucleic acid amplification process

Publications (1)

Publication Number Publication Date
ATE209258T1 true ATE209258T1 (de) 2001-12-15

Family

ID=23051486

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95929679T ATE209258T1 (de) 1994-07-15 1995-07-13 Verwendung von rna-polymerase zur verbesserung von nukeinsaeure-amplifikationsverfahren

Country Status (12)

Country Link
US (1) US6025134A (de)
EP (1) EP0776376B1 (de)
JP (1) JP3881009B2 (de)
KR (1) KR100392551B1 (de)
AT (1) ATE209258T1 (de)
AU (1) AU711115B2 (de)
CA (1) CA2195209C (de)
DE (1) DE69524105T2 (de)
DK (1) DK0776376T3 (de)
ES (1) ES2168380T3 (de)
PT (1) PT776376E (de)
WO (1) WO1996002668A1 (de)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712127A (en) * 1996-04-29 1998-01-27 Genescape Inc. Subtractive amplification
AU4938497A (en) 1996-11-12 1998-06-03 Visible Genetics Inc. Method and kit for direct isothermal sequencing of nucleic acids
ZA989950B (en) 1997-11-17 1999-05-04 Akzo Nobel Nv Transcription based amplification of double stranded DNA targets
ES2169943T3 (es) 1998-02-27 2002-07-16 Pamgene Bv Metodo para la amplificacion no especifica de acido nucleico.
WO2000000638A2 (en) * 1998-06-26 2000-01-06 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
WO2000006779A1 (en) * 1998-07-31 2000-02-10 Gen-Probe Incorporated Reversible inhibiting probes
WO2003064679A2 (en) 2002-01-30 2003-08-07 Id Biomedical Corporation Methods for detecting vancomycin-resistant microorganisms and compositions therefor
ATE443776T1 (de) 2002-05-17 2009-10-15 Us Gov Health & Human Serv Molekulare identifizierung von aspergillus- spezies
US20040018494A1 (en) * 2002-07-25 2004-01-29 Shurtliff Roxanne N Isothermal transcription based amplification assay for detection and quantification of guanylyl cyclase C
JP2006516883A (ja) 2002-09-19 2006-07-13 アメリカ合衆国 Ｐ．アリアシポリペプチド、ユウガイサシチョウバエポリペプチド、および使用法
DE60327366D1 (de) 2002-10-29 2009-06-04 Fundacao Oswaldo Cruz Lutzomyia longipalpis-polypeptide und verwendungsverfahren
CA2943039C (en) 2005-10-14 2018-11-06 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Rabies virus compositions and methods
SG10201806098QA (en) 2006-02-13 2018-08-30 Us Gov Health & Human Services Primers and probes for detection and discrimination of types and subtypes of influenza viruses
WO2007106536A2 (en) 2006-03-14 2007-09-20 Oregon Health & Science University Methods for producing an immune response to tuberculosis
CA2673870A1 (en) 2006-12-27 2008-07-10 Emory University Compositions and methods for the treatment of infections and tumors
CA2678404C (en) 2007-02-28 2019-03-19 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Brachyury polypeptides and methods for use
US8921074B2 (en) 2008-04-10 2014-12-30 Genenews, Inc. Method and apparatus for determining a probability of colorectal cancer in a subject
EP2353008A2 (de) 2008-09-22 2011-08-10 Oregon Health and Science University Verfahren zum nachweis einer infektion mit mycobacterium tuberculosis
MX2011005691A (es) 2008-11-28 2011-07-20 Univ Emory Metodos para el tratamiento de infecciones y tumores.
US20120004133A1 (en) 2009-02-20 2012-01-05 The Johns Hopkins University Method for the diagnosis of age-associated vascular disorders
WO2010138908A1 (en) 2009-05-29 2010-12-02 Ventana Medical Systems, Inc. Igfir gene copy number as a prognostic marker in a non-small cell lung cancer
AU2010253978B2 (en) 2009-05-29 2014-12-11 Ventana Medical Systems, Inc. Methods of scoring gene copy number in a biological sample using in situ hybridization
WO2010138926A1 (en) 2009-05-29 2010-12-02 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acids for detection and discrimination of genotypes of chlamydophila psittaci
US9175070B2 (en) 2009-09-25 2015-11-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Neutralizing antibodies to HIV-1 and their use
WO2011047340A1 (en) 2009-10-16 2011-04-21 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine
US8961989B2 (en) 2009-11-20 2015-02-24 Oregon Health & Science University Methods for producing an immune response to tuberculosis
AU2011243039B2 (en) 2010-04-16 2015-01-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Real time PCR assay for detection of bacterial respiratory pathogens
US9828637B2 (en) 2010-04-18 2017-11-28 Wake Forest University Health Sciences Methods of predicting predisposition to or risk of kidney disease
CN103068851B (zh) 2010-06-16 2015-03-11 高等教育联邦系统-匹兹堡大学 内质蛋白的抗体及其用途
US20130316338A1 (en) 2010-06-29 2013-11-28 The United States Government As Represented By The Department Of Veterans Affairs CCR6 As A Biomarker of Alzheimer's Disease
KR20140016865A (ko) 2010-08-30 2014-02-10 다우 아그로사이언시즈 엘엘씨 사탕수수 간균형 바이러스(scbv) 인핸서 및 식물 기능유전체학에서의 그의 용도
CN103221543B (zh) 2010-08-30 2016-10-05 陶氏益农公司 用于玉米的激活标签化平台和所得的带标签的群体和植物
SG192108A1 (en) 2011-01-25 2013-08-30 Almac Diagnostics Ltd Colon cancer gene expression signatures and methods of use
WO2012142164A1 (en) 2011-04-12 2012-10-18 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
US8741564B2 (en) 2011-05-04 2014-06-03 Htg Molecular Diagnostics, Inc. Quantitative nuclease protection assay (QNPA) and sequencing (QNPS) improvements
WO2013006684A1 (en) 2011-07-05 2013-01-10 The Gov. Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health And Human Services. Hiv-1 genotyping assay for global surveillance of hiv-1 drug resistance
WO2013049535A2 (en) 2011-09-30 2013-04-04 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Influenza vaccine
EP2780466B1 (de) 2011-11-15 2019-02-27 Université Libre de Bruxelles Streptococcus pneumoniae-nachweis im blut
RU2639517C2 (ru) 2012-02-29 2017-12-21 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Энхансер палочковидного вируса сахарного тростника (scbv) и его применение в функциональной геномике растений
CA2866185C (en) 2012-03-23 2021-04-06 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pathogenic phlebovirus isolates and compositions and methods of use
WO2013148147A1 (en) 2012-03-26 2013-10-03 The U.S.A., As Represented By The Secretary Dept. Of Health And Human Services Dna methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
WO2013152352A1 (en) 2012-04-06 2013-10-10 The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic Live, attenuated rubella vector to express vaccine antigens
AU2013252785B2 (en) 2012-04-27 2017-05-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of CpG oligonucleotides co-formulated with an antibiotic to accelarate wound healing
US9803251B2 (en) 2012-05-03 2017-10-31 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods of detecting influenza virus
US9394574B2 (en) 2012-06-12 2016-07-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods for detecting Legionella nucleic acids in a sample
US9631243B2 (en) 2012-06-18 2017-04-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and compositions for identifying JC virus
WO2014043518A1 (en) 2012-09-14 2014-03-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Brachyury protein, non-poxvirus non-yeast vectors encoding brachyury protein, and their use
US9775895B2 (en) 2012-12-12 2017-10-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services HIV therapeutics and methods of making and using same
DK2951290T3 (en) 2013-02-01 2018-01-22 Us Health PROCEDURE FOR PREPARING RETINAL PIGMENTAL EPIT (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCS)
US9534041B2 (en) 2013-02-12 2017-01-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Monoclonal antibodies that neutralize a norovirus
US10612088B2 (en) 2013-03-14 2020-04-07 The Broad Institute, Inc. Massively multiplexed RNA sequencing
JP2016518126A (ja) 2013-04-19 2016-06-23 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ローンスターウイルス
EP3583950A1 (de) 2013-05-09 2019-12-25 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Single-domain-vhh-antikörper gegen norovirus gi.1 und gii.4 und deren verwendung
EP3060686B1 (de) 2013-10-22 2018-08-01 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Zusammensetzungen und verfahren zur erkennung von influenzaviren
US10398772B2 (en) 2014-01-08 2019-09-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy
EP3107930A1 (de) 2014-02-21 2016-12-28 THE UNITED STATES OF AMERICA, represented by the S Hiv-2-nukleinsäuren und nachweisverfahren
US20170044631A1 (en) 2014-04-14 2017-02-16 The Unite States of America, as represented by the Secretary, Dept. of Health and Human Services Methods for rapid detection and identification of viral nucleic acids
WO2015199976A1 (en) 2014-06-24 2015-12-30 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Target activated microdissection
US20170252364A1 (en) 2014-07-30 2017-09-07 Mor Research Applications Ltd. Compositions for treatment of acute lymphoblastic leukemia and methods of use thereof
EP3177320B1 (de) 2014-07-31 2021-01-06 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Humane monoklonale antikörper gegen epha4 und deren verwendung
WO2016089920A1 (en) 2014-12-01 2016-06-09 The Broad Institute, Inc. Method for in situ determination of nucleic acid proximity
US10072070B2 (en) 2014-12-05 2018-09-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Potent anti-influenza A neuraminidase subtype N1 antibody
US10119172B2 (en) 2015-02-20 2018-11-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and reagents for detecting ebola virus
US11873483B2 (en) 2015-03-11 2024-01-16 The Broad Institute, Inc. Proteomic analysis with nucleic acid identifiers
AU2016308339A1 (en) 2015-08-18 2018-04-12 Baylor College Of Medicine Methods and compositions for altering function and structure of chromatin loops and/or domains
EP3359651A1 (de) 2015-10-05 2018-08-15 THE UNITED STATES OF AMERICA, represented by the S Stamm des menschlichen rota-virus g9p[6] und verwendung als impfstoff
WO2017192589A1 (en) 2016-05-02 2017-11-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Neutralizing antibodies to influenza ha and their use and identification
WO2017200790A1 (en) 2016-05-20 2017-11-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Real-time reverse transcriptase-polymerase chain reaction assay with modified probe for the diagnosis of rabies viruses and other lyssaviruses
WO2018005284A1 (en) 2016-06-27 2018-01-04 The United State Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and compositions for influenza a virus subtyping
WO2018039640A1 (en) 2016-08-26 2018-03-01 The Broad Institute, Inc. Nucleic acid amplification assays for detection of pathogens
MX2019006522A (es) 2016-12-06 2020-02-20 Univ Oregon State Composiciones y metodos para produccion mejorada de enduracidina en una cepa geneticamente modificada de streptomyces fungicidicus.
WO2018204175A1 (en) 2017-05-03 2018-11-08 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Rapid detection of zika virus by reverse transcription loop-mediated isothermal amplification
US11466329B2 (en) 2017-06-14 2022-10-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Detection of blaIMP antibacterial resistance genes
GB201710838D0 (en) 2017-07-05 2017-08-16 Ucl Business Plc Bispecific antibodies
WO2019060907A1 (en) 2017-09-25 2019-03-28 Fred Hutchinson Cancer Research Center HIGH PERFORMANCE TARGETED IN SITU PANGENOMIC PROFILING
WO2019071054A1 (en) 2017-10-04 2019-04-11 The Broad Institute, Inc. METHODS AND COMPOSITIONS FOR MODIFYING THE FUNCTION AND STRUCTURE OF BUCKLES AND / OR CHROMATIN DOMAINS
WO2019133727A1 (en) 2017-12-29 2019-07-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Universal influenza virus probe set for enrichment of any influenza virus nucleic acid
US11814674B2 (en) 2018-02-02 2023-11-14 The United States Of America, As Represented By The Secretary Department Of Health And Human Services Random amplification methods for extremely low input nucleic acids
AU2019309520B2 (en) 2018-07-27 2025-04-03 Aperta Biosciences, Llc Spinosyn formulations for treatment of demodex-induced ocular and facial conditions
US12188099B2 (en) 2018-12-12 2025-01-07 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Integrated proviral sequencing assay
WO2020210754A1 (en) 2019-04-10 2020-10-15 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Computational filtering of methylated sequence data for predictive modeling
ES3041245T3 (en) 2019-05-30 2025-11-11 Viti Inc Methods for detecting a mycobacterium tuberculosis infection
MX2022000973A (es) 2019-07-23 2022-04-06 Snapdna Sistema y método para detectar y monitorear patógenos.
US11844800B2 (en) 2019-10-30 2023-12-19 Massachusetts Institute Of Technology Methods and compositions for predicting and preventing relapse of acute lymphoblastic leukemia
WO2022056078A1 (en) 2020-09-11 2022-03-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Rnase h-assisted detection assay for rna (radar)
IL308870A (en) 2021-05-26 2024-01-01 Centarix Biotech Ltd Methods for identifying critically short telomeres
WO2024191684A1 (en) 2023-03-10 2024-09-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Detection of hepatitis c virus ribonucleic acid from whole blood using reverse transcription loop-mediated isothermal amplification

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340807C (en) * 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
US5130238A (en) * 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
WO1991001384A1 (en) * 1989-07-11 1991-02-07 Gen-Probe, Incorporated Nucleic acid sequence amplification methods utilizing a transcription complex
WO1991004340A1 (en) * 1989-09-20 1991-04-04 Cambridge Biotech Corporation In vitro, isothermal nucleic acid amplification
DE69029401T2 (de) * 1989-09-21 1997-07-10 Camborne Ind Plc Wiedergewinnung von schrott

Also Published As

Publication number Publication date
WO1996002668A1 (en) 1996-02-01
JPH11505402A (ja) 1999-05-21
EP0776376A1 (de) 1997-06-04
CA2195209C (en) 2008-09-23
DK0776376T3 (da) 2002-02-18
KR100392551B1 (ko) 2003-10-30
US6025134A (en) 2000-02-15
AU711115B2 (en) 1999-10-07
ES2168380T3 (es) 2002-06-16
CA2195209A1 (en) 1996-02-01
PT776376E (pt) 2002-05-31
DE69524105T2 (de) 2002-07-18
AU3336695A (en) 1996-02-16
DE69524105D1 (de) 2002-01-03
EP0776376B1 (de) 2001-11-21
JP3881009B2 (ja) 2007-02-14

Similar Documents

Publication Publication Date Title
DE69524105D1 (de) Verwendung von rna-polymerase zur verbesserung von nukeinsaeure-amplifikationsverfahren
DE69028257D1 (de) Verfahren zur Vervielfältigung von Nukleinsäuresequenzen
CA2398107C (en) Methods for analysis of gene expression
DK0970240T3 (da) Kunstig fejlparringshydridisering
ATE191934T1 (de) Verfahren zur isothermer amplifikation von nukleinsäure molekülen
ATE382095T1 (de) In-vitro verfahren zur bereitstellung von fragmenten für die dns sequenzierung
DK0487628T3 (da) Forbedret fremgangsmåde til nukleinsyre-amplifikation
CA2218476A1 (en) Diagnostic method
ATE426045T1 (de) Prozess zur synthetisierung von nukleinsaure
SE8700821D0 (sv) Quantitative determination of nucleic acid molecules and the reagent kit used
CY2406B1 (en) Assaying nucleotides in solution using pna probes.
ATE160822T1 (de) Identifizierung von salmonella durch die polymerase-ketten-reaktion
DK1504098T3 (da) Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion
EP0780479A3 (de) Verfahren zum quantitativen Nachweis von Spezifischen Nukleinsäuresequenzen
ATE359369T1 (de) Rns-abhängige rns-polymerase, die vorzugsweise anhand einer rna-matrix funktioniert und ein promoter-abhängiger transkriptionsprozess , der diese rns-abhängige rns-polymerase benutzt.
ATE204331T1 (de) Verfahren und system zur molekularbiologischen diagnose
TW329476B (en) Method for detecting contaminant DNA in a protein product and kits used for the same purpose
DE50115782D1 (de) THERMOSTABILE POLYMERASE AUS i THERMOCOCCUS PACIFICUS /i
WO1998049341A3 (en) Polynucleotide sequencing using semi-degenerate primers
Valle PCR-based method to map the bending locus of DNA molecules.
WO2001040510A3 (de) Dynamische sequenzierung durch hybridisierung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0776376

Country of ref document: EP